COMMUNIQUÉS West-GlobeNewswire

Turning Point Therapeutics’ CEO to Present at Goldman Sachs 40th Annual Global Healthcare Conference
04/06/2019
SAN DIEGO, June 04, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, announced that President and CEO Athena [...]
Oncology Researcher Andrew Quong Joins Fluidigm as Chief Science Officer
04/06/2019
SOUTH SAN FRANCISCO, Calif., June 04, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Andrew Quong, PhD, has joined the company as its first-ever Chief Science Officer. Quong will lead [...]
Eyenovia Enrolls First Patient in Phase III CHAPERONE Study for Progressive Myopia
04/06/2019
Program Follows Successful Completion of Phase III Program in Mydriasis NEW YORK, June 04, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a [...]
Myovant Sciences to Present at Upcoming June Investor Conferences
04/06/2019
BRISBANE, California and BASEL, Switzerland, June 04, 2019 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV ), a clinical-stage healthcare company focused on developing and commercializing innovative therapies for women [...]
Obalon Announces Issuance of First U.S. Patent Covering Its Proprietary Navigation System
04/06/2019
Expands the Company’s intellectual property estate to 20 issued US patents SAN DIEGO, June 04, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with [...]
Caladrius Biosciences Completes Enrollment in Phase 2 ESCaPE-CMD Trial for Coronary Microvascular Dysfunction
04/06/2019
Topline results expected by the end of 2019 BASKING RIDGE, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development [...]
Catalyst Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference
04/06/2019
CORAL GABLES, Fla., June 04, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Philips and University of Vermont Health Network sign 10-year agreement to improve patient care
04/06/2019
June 4, 2019 Long-term, strategic partnership builds on clinical excellence to improve care and optimize workflows for enhanced patient and staff experience Amsterdam, the Netherlands, and Burlington, U.S. – Royal [...]
Progressive Care Inc. Completes Acquisition of Family Physicians Rx
04/06/2019
MIAMI, June 04, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, announced today that it has closed on the acquisition of Family Physicians RX, [...]
Rafael Pharmaceuticals to Present at the 2019 Jefferies Global Healthcare Conference
04/06/2019
Newark, NJ, June 04, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, will present at the Jefferies 2019 [...]
BeyondSpring to Present at the Jefferies 2019 Healthcare Conference
04/06/2019
NEW YORK, June 04, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, announced today that management will provide a [...]
Foamix Announces Publication of Phase 3 FMX101 Acne Study in Journal of American Academy of Dermatology
04/06/2019
REHOVOT, Israel and BRIDGEWATER, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical-stage pharmaceutical company that specializes in developing and commercializing proprietary [...]
VBI Vaccines Reports Data from Part A of the Ongoing Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients at ASCO 2019
04/06/2019
Well tolerated at all doses with no safety signals Three patients in high dose (10 µg) cohort showed evidence of stable disease by MRI 10 µg dose selected for Part B of the study, which is expected to initiate [...]
ASLAN Pharmaceuticals Completes Phase 1 Study for ASLAN004 Targeting Atopic Dermatitis
04/06/2019
- Final results from single ascending dose study confirm ASLAN004’s favourable tolerability profile, complete inhibition of downstream mediators and potential for monthly dosing SINGAPORE, June 04, 2019 (GLOBE NEWSWIRE [...]
Allena Pharmaceuticals Announces Interim Results from Study 206 of Reloxaliase in High Risk Patients with Advanced Oxalate Disorders
04/06/2019
-- Substantial Treatment Effect Observed in Patients with Enteric Hyperoxaluria, Including Robust Reductions in Both Urine and Plasma Oxalate – -- Reloxaliase Well-Tolerated Over 12 Weeks of Dosing -- -- Detailed [...]
Cambrex Completes New Process and Analytical Development Facility at its Karlskoga, Sweden Manufacturing Site
04/06/2019
EAST RUTHERFORD, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]
Allogene Therapeutics Announces FDA Clearance of the IND for ALLO-715, a BCMA Allogeneic CAR T (AlloCAR T™) Therapy
04/06/2019
ALLO-715 Utilizes Gene-Editing of TRAC and CD52 Loci to Enable Allogeneic CAR T Therapy ALLO-715 will be Evaluated in Combination with ALLO-647, Allogene’s Proprietary anti-CD52 Antibody as Part of the Lymphodepletion [...]
NexoBrid® Receives Marketing Authorization from Peru’s Ministry of Health
04/06/2019
Avalon Pharmaceutical Peru S.A.C., MediWound’s exclusive distributor, plans commercial launch for first half of 2020 YAVNE, Israel, June 04, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated [...]
TG Therapeutics to Present at the Jefferies 2019 Healthcare Conference
04/06/2019
Presentation scheduled for tomorrow, Wednesday, June 5, 2019, at 9:00 AM ET NEW YORK, June 04, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s [...]

Pages